-
Document de presse | 2022.05.18
Phage Therapy: A Model to Predict Its Efficacy against Pathogenic Bacteria
Antibiotic resistance represents a major public health challenge, associated with a high mortality rate. While bacteriophages – viruses that kill bacteria – could be a solution for fighting antibiotic-resistant pathogens, various obstacles stand in the way of their clinical development. To overcome them, researchers from Inserm, Université Sorbonne Paris Nord and Université Paris-Cité at the IAME...
-
Article | 2022.05.30
Afroscreen Project : boosting variant surveillance in 13 african countries
The Agence française de développement (AFD) and ANRS | Maladies infectieuses émergentes, in partnership with the Institut Pasteur, IRD, and laboratories across 13 African countries, are launching the joint AFROSCREEN project. This project meets an urgent need for surveillance of the development of SARS-CoV-2 variants and other emerging pathogens by bolstering laboratory genomic sequencing...
-
Article | 2022.05.31
Ethics and Compliance Committee
At its meeting on March 5, 2018, the Board of Governors adopted a revised Charter for the Prevention and Management of Conflicts of Interest. At the same time, the Board decided to set up an Ethics and Compliance Committee tasked with issuing opinions and recommendations to guide the Board of Governors and the President and ensuring that the principles in the Charter are applied.
-
Document de presse | 2022.05.23
Stromal cells, maestros of the intestine
The intestine is responsible for absorbing nutrients while protecting the body from external aggression, a task performed by a complex intestinal barrier. Scientists from the Institut Pasteur demonstrated in a mouse model that a population of tissue-resident cells known as stromal cells is crucial for the development of a functional intestinal barrier in the first few weeks after birth. Absence...
-
News | 2022.06.07
Small/medium-sized companies in the healthcare sector: see you at Pasteur Innov’ Day!
Are you a small or medium-sized company in the healthcare sector and are you looking for a collaborator of choice to overcome a scientific or technological barrier? Register for Pasteur Innov' Day on July 7, 2022, and come and discover some of our iconic innovations. The Pasteur Innov’ day is an opportunity to meet our scientific experts and business managers to discuss your innovation projects...
-
Document de presse | 2022.06.07
Institut Pasteur and MSDAVENIR sign a partnership to improve strategies for controlling the spread of vector-borne viral diseases like Zika
The Institut Pasteur and MSDAVENIR, a health research endowment fund by MSD, signed an important partnership to anticipate responses to future vector-borne viral epidemics today. The partnership, worth more than €1.7 million, will support the INTRANZIGEANT project led by Dr. Louis Lambrechts, head of the Virus-Insect Interactions Unit, and Xavier Montagutelli, head of the Mouse Genetics...
-
News | 2022.06.08
The role of social sciences in the response to an epidemic: the example of the COVID-19 pandemic
A lesser known but equally crucial dimension in managing and responding to an epidemic is social sciences in health, which can shed light on populations' understanding, perception and acceptance of the risks associated with diseases. The COVID-19 pandemic is no exception. As the disease spread across the planet, clear differences in perception by populations were observed in different countries,...
-
News | 2021.12.09
research, education, and economic development: first assessment of 3ia network actions
At the intersection of public and private research, the 3IA institutes create the ideal conditions for collaboration between world-class academic researchers and key drivers of innovation (start-ups, SMEs, or large corporations) and thereby strengthen the economic vitality of their environment. Although they each have their unique features, the 3IA insitutes also work in a network. Since...
-
News | 2021.09.21
Launch of the Medtech Generator & Accelerator program
The support project Medtech Generator & Accelerator (MGA), selected as a winning project in the second SIA call for proposals under the French government's Investing in the Future scheme (operated by Bpifrance), began in September 2021. Developed jointly by the Brain and Spine Institute, the Institut Imagine, the Institut Pasteur and the Institut de la Vision, the program aims to...
-
News | 2021.09.07
The Institut Pasteur attends the Cap’Carnot event on September 28, 2021
Cap'Carnot is the annual summer event organized by the Association of Carnot Institutes to promote dialog between the Carnot Institutes and drivers of innovation. For its second edition, Cap'Carnot will be held on Tuesday September 28, 2021 from 5 to 8pm at NEWCAP in Paris’ 15th arrondissement, and will be an opportunity to celebrate 15 years of R&D initiatives by Carnot...
